RESEARCH
13 Feb 2026
REGULATORY
12 Feb 2026
INNOVATION
11 Feb 2026
PARTNERSHIPS
10 Feb 2026

INVESTMENT
9 Feb 2026
SonoVascular’s $6M raise highlights rising interest in investigational ultrasound tools aimed at safer, more targeted clot treatment

MARKET TRENDS
16 Oct 2025
A push to make high-dose biologics easier and faster to deliver

TECHNOLOGY
15 Oct 2025
Halozyme’s Elektrofi deal could turn complex infusions into quick, patient-friendly injections

PARTNERSHIPS
14 Oct 2025
New partnership weaves delivery into early biologic design, sparking cautious optimism for future impact

INSIGHTS
13 Oct 2025
US firms pioneer wearable and greener drug-delivery systems as biologics reshape patient care

RESEARCH
10 Oct 2025
Halozyme’s $900M Elektrofi deal aims to speed up and simplify injectable biologic treatments

INNOVATION
8 Oct 2025
Merck’s subcutaneous Keytruda Qlex offers faster cancer dosing, though IV remains the mainstay for most patients.
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.